Section 820.45 establishes FDA-specific DEVICE LABELLING + PACKAGING controls supplementing ISO 13485:2016 Section 7.5.11 (preservation of product). REQUIREMENTS: (a) LABELLING - the manufacturer must establish + maintain procedures to control labelling activities to ensure that LABELLING IS LEGIBLE + DURABLE + AFFIXED OR ATTACHED to the device + APPROPRIATE LABELLING IS RELEASED FOR COMMERCIAL USE - including device identification + manufacturer name + intended use + warnings + cautions + instructions for use (IFU). (b) UDI ON LABEL - the UDI must appear on the LABEL OF THE DEVICE + on each higher level of packaging in human-readable + AIDC (Automatic Identification and Data Capture) format per 21 CFR Part 830. (c) LABELLING INSPECTION + STORAGE - procedures for inspection of labelling for accuracy including identification number + lot number + expiration date + control number + similar information; secure storage of labelling + control of access. (d) LABELLING OPERATIONS - control of labelling operations to prevent mix-ups; controlled environment where labelling is performed; supervision of labelling operations; documentation of labelling operations. (e) PACKAGING - packaging must be designed + constructed to protect the device from alteration + damage during processing + storage + handling + distribution + use. (f) PACKAGING VALIDATION - validation of packaging design per ISO 11607-1 + 11607-2 (Packaging for Terminally Sterilized Medical Devices) where applicable.
The graph holds this control, the 0 it maps to, and the evidence behind each claim, over MCP and REST.